Global Hormone Replacement Therapy Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 69

Global Hormone Replacement Therapy Market 2015-2019

Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

An overview of the hormone replacement therapy market

Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. The expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

Segmentation of the hormone replacement therapy market by type of hormonal therapy

  • Estrogen replacement therapy
  • Growth hormone replacement therapy

With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.

Segmentation of the hormone replacement therapy market by route of administration

  • Oral
  • Parenteral
  • Transdermal

The oral route of administration is a sub-division of enteral administration and is regarded as one of the safest and most preferred routes of drug administration. Some of the drug that are administered orally are Premarin and Estrace.

Competitive landscape and key vendors

The global hormone replacement therapy market is a mature market, which is extremely competitive due to the presence of a huge number of small and large vendors. Therefore, development of low-dose oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected to captivate the attention of players in the hormonal replacement market.

Key vendors in this market are -

  • F. Hoffmann-La Roche
  • Merck Serono
  • Novartis
  • Novo Nordisk
  • Pfizer

Other prominent vendors included in this report are Abbott Laboratories, Amgen, ANI Pharmaceuticals, Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries, and Therapeutics MD.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global hormone replacement therapy market?
  • What are the key market trends impacting the growth of the global hormone replacement therapy market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global hormone replacement therapy market?
  • What are the market opportunities and threats faced by the vendors in the global hormone replacement therapy market?
  • What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
  • What are the key outcomes of the five forces analysis of the global hormone replacement therapy market?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Coronary Disease Global Clinical Trials Review, H2, 2017

Coronary Disease Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Coronary Disease Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H2, 2017

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Deafness Global Clinical Trials Review, H2, 2017

Deafness Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Deafness Global Clinical Trials Review, H2, 2017" provides an overview of Deafness clinical trials scenario. This report provides top line data relating to the clinical trials on Deafness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Coronary Stenosis Global Clinical Trials Review, H2, 2017

Coronary Stenosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Coronary Stenosis Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2017

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's pro......
$2500

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2017

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2017" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical trials on Deep Vein Thrombosis (DVT). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary dat......
$2500

Coronary Thrombosis Global Clinical Trials Review, H2, 2017

Coronary Thrombosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinic......
$2500

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous T-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2017

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H2, 2017" provides an overview of Corrosive Esophagitis (Erosive Esophagitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Corrosive Esophagitis (Erosive Esophagitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Cli......
$2500

Cyst Global Clinical Trials Review, H2, 2017

Cyst Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Cyst Global Clinical Trials Review, H2, 2017" provides an overview of Cyst clinical trials scenario. This report provides top line data relating to the clinical trials on Cyst. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ di......
$2500